Suzanne Gaudet

Boston Biomedical (United States) — United States

Computer Science · Physical Sciences

24h-index4.4kcitations71works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(12), Gene Regulatory Network Analysis(9), NF-κB Signaling Pathways(8), Protein Kinase Regulation and GTPase Signaling(7), Immune Response and Inflammation(6)

Publications71 total

Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor
npj Drug Discovery.·2025Open Access
Foundational Principles for the Quantitative Translation of T‐Cell Therapeutics for Hematologic Malignancies and Immunology
Clinical Pharmacology & Therapeutics·2025Open Access
Viral Kinetics Model of SARS‐CoV‐2 Infection Informs Drug Discovery, Clinical Dose, and Regimen Selection
Clinical Pharmacology & Therapeutics·2024· 6 citedOpen Access
Supplementary Figures from Inhibition of <i>KRAS</i>-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
2023Open Access
Supplementary Figures from Inhibition of <i>KRAS</i>-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
2023Open Access
Supplementary Table from Inhibition of <i>KRAS</i>-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
2023Open Access
Supplementary Information from Inhibition of <i>KRAS</i>-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
2023Open Access
Data from Inhibition of <i>KRAS</i>-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
2023Open Access
Supplementary Information from Inhibition of <i>KRAS</i>-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
2023Open Access
Supplementary Table from Inhibition of <i>KRAS</i>-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
2023Open Access
Data from Inhibition of <i>KRAS</i>-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
2023Open Access
WALLABY pilot survey: Public release of H <scp>i</scp> data for almost 600 galaxies from phase 1 of ASKAP pilot observations
Publications of the Astronomical Society of Australia·2022· 42 citedOpen Access
TNF stimulation primarily modulates transcriptional burst size of NF‐κB‐regulated genes
Molecular Systems Biology·2021· 32 citedOpen Access
TNF stimulation primarily modulates transcriptional burst size of NF-κB-regulated genes
2020· 2 citedOpen Access
Considering Abundance, Affinity, and Binding Site Availability in the NF-κB Target Selection Puzzle
Frontiers in Immunology·2019· 38 citedOpen Access
The Impact of Allelic Imbalance on Signal Transmission Strongly Depends on Network Motif Properties
Biophysical Journal·2019
Fold-Change Detection of NF-κB at Target Genes with Different Transcript Outputs
Biophysical Journal·2019· 22 citedOpen Access
Fold-change detection of NF-κB at target genes with different transcript outputs
2018· 1 citedOpen Access
NF-κB-Chromatin Interactions Drive Diverse Phenotypes by Modulating Transcriptional Noise
Cell Reports·2018· 53 citedOpen Access
Faculty Opinions recommendation of Catch and Release of Cytokines Mediated by Tumor Phosphatidylserine Converts Transient Exposure into Long-Lived Inflammation.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature·2017
page 1 of 4Next →

Frequent Co-authors

Peter K. Sorger(15), John G. Albeck(9), Douglas A. Lauffenburger(7), Sabrina L. Spencer(6), Kathryn Miller‐Jensen(6), Kevin A. Janes(5), David A. Barbie(5), Robin Lee(4), Zehua Zhu(4), Amir Reza Aref(4), Travis J. Cohoon(4), Thanh U. Barbie(4), Yu Imamura(4), Susan E. Moody(4), Rhine R. Shen(4), Anna C. Schinzel(4), Tran C. Thai(4), Jacob B. Reibel(4), Pablo Tamayo(4), Zhi Rong Qian(4)